ViiV registers two HIV studies: DDI trial for VH4011499 and NIAID-led PALACE trialNov 16Weekly roundup, 2 itemscabotegravirGilead Sciences
Traws reports final Phase 2a ratutrelvir data, completes TXM tablet bridging studyNov 12Clinical readoutTraws Pharma, Inc.